YuanBio Venture Capital, also known as bioVenture, has filed with the US Securities and Exchange Commission (SEC) to raise a new fund that is likely to continue to invest in life sciences and healthcare companies.
Continue reading this premium story with a subscription to DealStreetAsia.
SubscribeAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com